Gerson Lehrman Group - Intelligently Connecting Institutions and Expertise.

Expert Insights on Diabetes

Diabetes is a disease characterized by the body's inability to sufficiently produce insulin to properly metabolize carbohydrates. The three main forms the condition are Type 1, Type 2, and gestational diabetes. Type 1 diabetes is a chronic disease characterized by destruction of beta-cells of the pancreas. Type 2 diabetes develops when the body becomes resistant to the effects of insulin. Gestational diabetes is usually a temporary disorder occurring during pregnancy when insulin resistance develops due to hormonal changes and weight gain.

Gerson Lehrman Group Council Members are available to discuss Diabetes via phone consultations, live meetings, surveys, and other custom GLG products and services.

Find, engage, and manageSM experts today through the GLG platform

Featured Council Members

GLG Council Members are leading experts including academics, scientists, and industry specialists

Michael Dempsey, Medical Director, SUBURBAN HOSPITAL, INC

Michael DempseyWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Medical DirectorSUBURBAN HOSPITAL, INC

Marina Raikhel, Director, TORRANCE MEMORIAL MEDICAL CENTER

Marina RaikhelWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

DirectorTORRANCE MEMORIAL MEDICAL CENTER

Richard Levy, Assistant Professor of Medicine and Pediatrics, RUSH UNIVERSITY MEDICAL CENTER

Richard LevyWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Assistant Professor of Medicine and PediatricsRUSH UNIVERSITY MEDICAL CENTER

Kelly Close, President, Close Concerns

Kelly CloseWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

PresidentClose Concerns

Satish Garg, Professor of Medicine and Pediatrics , REGENTS OF THE UNIVERSITY OF COLORADO

Satish GargWhat is a GLG Leader?|GLG Leaders are a separate tier of Council Members with a Council Rank in the top 5%. These GLG Member Program participants are eligible for ongoing, in-depth consultative relationships with GLG clients.

Professor of Medicine and Pediatrics REGENTS OF THE UNIVERSITY OF COLORADO

Browse all 424 Leading Experts

Study Groups

Study groups are populations of experts knowledgeable on specific sub-topics within a broader industry

Study Group Name No. Members
Byetta Prescribers for Diabetes 261
Byetta Prescribers for Diabetes (US) 229
Byetta Prescribers for Diabetes: Endocrinologists 150
Physicians who Treat Diabetes (US) 466
Byetta Prescribers for Diabetes: Endocrinologists (US) 126

Browse all 974 Study Groups

Recent News Analyses

News analyses are expert commentaries on current events, written by Council Members who are available for follow up consultations

Fresh Hope for Diabetes Patients

October 15, 2009

GLG Expert Contributor

Is the End of the Beginning of Diabetes Coming?

October 11, 2009

GLG Expert Contributor

Clinical efficacy for Linagliptin - results from phase III trials

September 29, 2009

GLG Expert Contributor

Major Turnaround- NEJM VADT Correction Shows MVC Benefits of Intensive Control

October 19, 2009

Kelly Close, President, Close Concerns

Boehringer Ingelheim Announces Conclusion of Phase 3 Clinical Trials

October 1, 2009

Kelly Close, President, Close Concerns

Browse all 7849 GLG News Analyses

Contact Gerson Lehrman Group to engage a Diabetes expert